A prospective observational study to evaluate impact of oral supplementation with AHCC and Lactobacillus Crispatus M247 on HPV clearance and low-grade squamous intraepithelial lesion regression
Vincenzino Salimbeni, Canio Martinelli, Lavinia Porto, M. Donne, Angela Alibrandi, Francesco Di Pierro, Flaviana Cau, R. Granese, Vito Iannone, Liliana Marchetta, Alfredo Ercoli, Combining Ahcc, L. Crispatus
{"title":"A prospective observational study to evaluate impact of oral supplementation with AHCC and Lactobacillus Crispatus M247 on HPV clearance and low-grade squamous intraepithelial lesion regression","authors":"Vincenzino Salimbeni, Canio Martinelli, Lavinia Porto, M. Donne, Angela Alibrandi, Francesco Di Pierro, Flaviana Cau, R. Granese, Vito Iannone, Liliana Marchetta, Alfredo Ercoli, Combining Ahcc, L. Crispatus","doi":"10.48286/aro.2024.83","DOIUrl":null,"url":null,"abstract":": Human papillomavirus (HPV), especially high-risk types like HPV 16 and 18, can progress from low-grade lesions (LSIL) to cancer. While HR-HPV and LSIL often regress naturally, some cases may advance to malignancy. Current treatments vary in efficacy and can have adverse effects. Emerging research on Lactobacillus Crispatus M247 and Active Hexose Correlated Compound (AHCC) shows potential for enhancing HPV clearance and LSIL regression with minimal side effects. However, the precise impact of these treatments remains under study","PeriodicalId":148778,"journal":{"name":"Annals of Research in Oncology","volume":"13 8","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Research in Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.48286/aro.2024.83","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
: Human papillomavirus (HPV), especially high-risk types like HPV 16 and 18, can progress from low-grade lesions (LSIL) to cancer. While HR-HPV and LSIL often regress naturally, some cases may advance to malignancy. Current treatments vary in efficacy and can have adverse effects. Emerging research on Lactobacillus Crispatus M247 and Active Hexose Correlated Compound (AHCC) shows potential for enhancing HPV clearance and LSIL regression with minimal side effects. However, the precise impact of these treatments remains under study
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
